Magnesium Migraine Meta-analysis: What the Evidence Says

Quick Answer

Magnesium Migraine Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Increased estradiol levels during pregnancy and breastfeeding are hypothesized to enhance susceptibility to Cortical Spreading Depression (CSD), thereby triggering or worsening aura attacks. [Braca Simone (2026); evidence level 1]
• Evidence regarding therapies such as CGRP-targeted monoclonal antibodies (mAbs), gepants (CGRP receptor antagonists), and triptans (serotonin 5-HT1B/1D receptor agonists) is mixed, with reported sex differences in efficacy, recurrence, and adverse events. [Braca Simone (2026); evidence level 1]
• Hormonal shifts during breastfeeding might also affect migraine occurrence, although the evidence is not definitive. [Rodriguez Juan Pablo (2025); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For magnesium migraine meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Braca Simone (2026). Sex-specific management of migraine a systematic review and consensus statement from the European Headache Federation (EHF). DOI: 10.1186/s10194-026-02350-x. PMCID: PMC13126917. PMID: 41998499. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13126917/
• Rodriguez Juan Pablo (2025). Magnesium supplementation for migraine prophylaxis. DOI: 10.1002/14651858.CD016307. PMCID: PMC12604082. PMID: 41216917. License: https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Attribution-Non-Commercial Licence This is an open a.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12604082/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.